title: Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease.
authors.forename: N
authors.initials: N
authors.lastname: Andreasen
authors.forename: J
authors.initials: J
authors.lastname: Gottfries
authors.forename: E
authors.initials: E
authors.lastname: Vanmechelen
authors.forename: H
authors.initials: H
authors.lastname: Vanderstichele
authors.forename: P
authors.initials: P
authors.lastname: Davidson
authors.forename: K
authors.initials: K
authors.lastname: Blennow
authors.forename: L
authors.initials: L
authors.lastname: Rosengren
authors.forename: K
authors.initials: K
authors.lastname: Blennow
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000134:cerebrospinal fluid*; D005260:Female; D005911:Gliosis / Q000134:cerebrospinal fluid / Q000175:diagnosis*; D006801:Humans; D008297:Male; D009410:Nerve Degeneration / Q000134:cerebrospinal fluid / Q000175:diagnosis*; D009419:Nerve Tissue Proteins / Q000134:cerebrospinal fluid*; D011237:Predictive Value of Tests; D012183:Retrograde Degeneration / Q000134:cerebrospinal fluid / Q000175:diagnosis*
chemical_list: D015415:Biomarkers; D009419:Nerve Tissue Proteins